Literature DB >> 20580121

Migration of dendritic cells from murine skeletal muscle.

Lei Wang1, Saman Eghtesad, Paula R Clemens.   

Abstract

To better understand the role of dendritic cells (DCs) in skeletal muscle, we investigated the migration of DCs from murine skeletal muscle and compared that to previously studied footpad (FP) DC trafficking. We adoptively transferred carboxyfluorescein diacetate succinimidyl ester (CFSE)-labeled mature DCs to syngeneic mice and followed them in various lymphatic tissues at different time points. Injection of DCs into the tibialis anterior muscle resulted in the peak number of CFSE(+) DCs recovered in spleen at 12h, not at 24h, when the largest number of these cells appeared in the draining lymph nodes. Interestingly, this result for adoptive transfer of DCs to skeletal muscle differs with what is previously reported for adoptive transfer to the FP, a result that we also confirmed in parallel studies. These findings could have a significant impact on (1) understanding muscle diseases with immunological complications such as muscular dystrophies and (2) the immunologic effects of treatments for muscle diseases. Published by Elsevier GmbH.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20580121      PMCID: PMC2974789          DOI: 10.1016/j.imbio.2010.04.006

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  34 in total

1.  Dendritic cells: the immune information management experts.

Authors:  Tim R Mosmann; Alexandra M Livingstone
Journal:  Nat Immunol       Date:  2004-06       Impact factor: 25.606

2.  High-level dystrophin expression after adenovirus-mediated dystrophin minigene transfer to skeletal muscle of dystrophic dogs: prolongation of expression with immunosuppression.

Authors:  J M Howell; H Lochmüller; A O'Hara; S Fletcher; B A Kakulas; B Massie; J Nalbantoglu; G Karpati
Journal:  Hum Gene Ther       Date:  1998-03-20       Impact factor: 5.695

3.  In vivo migration of dendritic cells differentiated in vitro: a chimpanzee model.

Authors:  S M Barratt-Boyes; S C Watkins; O J Finn
Journal:  J Immunol       Date:  1997-05-15       Impact factor: 5.422

4.  Immunology of gene therapy with adenoviral vectors in mouse skeletal muscle.

Authors:  Y Yang; S E Haecker; Q Su; J M Wilson
Journal:  Hum Mol Genet       Date:  1996-11       Impact factor: 6.150

5.  Dystrophin expression in muscles of mdx mice after adenovirus-mediated in vivo gene transfer.

Authors:  G Acsadi; H Lochmüller; A Jani; J Huard; B Massie; S Prescott; M Simoneau; B J Petrof; G Karpati
Journal:  Hum Gene Ther       Date:  1996-01-20       Impact factor: 5.695

6.  Isolation of human blood dendritic cells using the CMRF-44 monoclonal antibody: implications for studies on antigen-presenting cell function and immunotherapy.

Authors:  D B Fearnley; A D McLellan; S I Mannering; B D Hock; D N Hart
Journal:  Blood       Date:  1997-05-15       Impact factor: 22.113

7.  Ex vivo gene transfer using adenovirus-mediated full-length dystrophin delivery to dystrophic muscles.

Authors:  S S Floyd; P R Clemens; M R Ontell; S Kochanek; C S Day; J Yang; S D Hauschka; L Balkir; J Morgan; M S Moreland; G W Feero; M Epperly; J Huard
Journal:  Gene Ther       Date:  1998-01       Impact factor: 5.250

8.  Transient immunosuppression by FK506 permits a sustained high-level dystrophin expression after adenovirus-mediated dystrophin minigene transfer to skeletal muscles of adult dystrophic (mdx) mice.

Authors:  H Lochmüller; B J Petrof; G Pari; N Larochelle; V Dodelet; Q Wang; C Allen; S Prescott; B Massie; J Nalbantoglu; G Karpati
Journal:  Gene Ther       Date:  1996-08       Impact factor: 5.250

9.  CTLA4Ig delivered by high-capacity adenoviral vector induces stable expression of dystrophin in mdx mouse muscle.

Authors:  Z Jiang; G Schiedner; S C Gilchrist; S Kochanek; P R Clemens
Journal:  Gene Ther       Date:  2004-10       Impact factor: 5.250

10.  Analysis of dendritic cell trafficking using EGFP-transgenic mice.

Authors:  Andreas A O Eggert; Robbert van der Voort; Ruurd Torensma; Veronique Moulin; Otto C Boerman; Wim J G Oyen; C J A Punt; Heleen Diepstra; Annemiek J de Boer; Carl G Figdor; Gosse J Adema
Journal:  Immunol Lett       Date:  2003-10-09       Impact factor: 3.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.